Mary Miller - 17 Apr 2025 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Signature
/s/ Adam D. Levy, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
17 Apr 2025
Net transactions value
-$1,010
Form type
4
Filing time
18 Apr 2025, 15:51:24 UTC
Previous filing
03 Apr 2025
Next filing
16 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability $1,010 -558 -1.5% $1.81 36,507 17 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.